In Vivo is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Brought to you by

Vantia brings in £19mm with its Series A venture round

Executive Summary

Vantia (spin-off of Ferring Pharmaceuticals AS; urological and gynecological conditions) has raised £19mm ($38.4mm) through its Series A venture round from a group of investors, including lead backer MVM Life Science Partners, SV Life Sciences, and Novo AS.
Deal Industry
  • Biotechnology
  • Pharmaceuticals
Deal Status
  • Final
Deal Type
  • Financing
    • Venture Financing

Related Companies